Fundz
New|Fundz now works inside Claude2 min

Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.

Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for FS001 antibody-drug conjugate

Jul 11, 2024

Contract Type

agreement

ParisBiotechnology

Description

Ipsen and Foreseen Biotechnology have announced an exclusive global licensing agreement for FS001, an antibody-drug conjugate (ADC) with first-in-class potential. FS001 targets a novel tumor-associated antigen with the potential to unlock critical new treatments for people living with hard-to-treat forms of cancer.

Company Information

Company

Ipsen and Foreseen Biotechnology

Location

Paris, Ile-de-France, France

About

Ipsen is a global biopharmaceutical group focused on innovation and specialty care. Foreseen Biotechnology is a biotechnology company with a focus on discovering and developing innovative therapeutic products.

Predictive Intelligence
Strategic

ML-powered predictions for Ipsen and Foreseen Biotechnology's next move

Learn about Strategic plan

Ipsen and Foreseen Biotechnology signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.